Trial Profile
A placebo-controlled, phase 2, randomised, crossover, double-blind study investigating efficacy and safety of Esmirtazapine in patients with primary insomnia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Oct 2016
Price :
$35
*
At a glance
- Drugs Esmirtazapine (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 18 Oct 2016 New trial record